Literature DB >> 3592060

Gastric carcinoid associated with the syndrome of hypergastrinemic atrophic gastritis. A prospective analysis of 11 cases.

K Borch, H Renvall, E Kullman, E Wilander.   

Abstract

The prevalence of gastric carcinoid in fundic atrophic gastritis is probably greater than previously recognized. To help elucidate the clinicopathology of this syndrome, we report a series of 11 patients with solitary or multicentric carcinoid tumors. In these patients, basal gastrin levels and density of fundic mucosal endocrine cells were greater than that for patients with uncomplicated fundic atrophic gastritis (p = 0.02 and p = 0.002, respectively). The polypoid tumors, of which the largest measured 30 mm, frequently showed characteristic endoscopic features. They were all situated in the fundic mucosa, which showed micronodular endocrine cell hyperplasia. Small, endoscopically evident tumorlets, or "early carcinoids," limited to the lamina propria were observed in some patients. These lesions may represent intermediate stages between micronodules and invasive carcinoids, all of which infiltrated at least into the muscularis mucosae of the gastric wall. Although some consistent characteristics features were noted, there were structural variations. The cells were argyrophil but nonargentaffin and did not stain with conventional mucus stains. They did not stain significantly for carcinoembryonic antigen (CEA). The secretory product of these tumors remains to be identified. Ultrastructurally, some tumors were mainly composed of enterochromaffinlike (ECL) cells, but in other tumors most of the cells could not be classified.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3592060     DOI: 10.1097/00000478-198706000-00004

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  17 in total

1.  Smooth Muscle Cell Abnormalities Associated with Gastric ECL Cell Carcinoids.

Authors:  Cesare Bordi; Pietro Caruana; Tiziana D'Adda; Cinzia Azzoni
Journal:  Endocr Pathol       Date:  1995       Impact factor: 3.943

2.  Gastric neuroendocrine carcinoma associated with chronic atrophic gastritis type A.

Authors:  Y Kaizaki; T Fujii; T Kawai; K Saito; K Kurihara; M Fukayama
Journal:  J Gastroenterol       Date:  1997-10       Impact factor: 7.527

3.  Long-term follow up of endoscopic resection for type 3 gastric NET.

Authors:  Yong Hwan Kwon; Seong Woo Jeon; Gwang Ha Kim; Jin Il Kim; Il-Kwun Chung; Sam Ryong Jee; Heung Up Kim; Geom Seog Seo; Gwang Ho Baik; Kee Don Choi; Jeong Seop Moon
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

4.  Mucosal argyrophil endocrine cells in pernicious anaemia and upper gastrointestinal carcinoid tumours.

Authors:  S M Sjöblom; P Sipponen; S L Karonen; H J Järvinen
Journal:  J Clin Pathol       Date:  1989-04       Impact factor: 3.411

5.  Increased incidence of pancreatic neoplasia in pernicious anemia.

Authors:  K Borch; E Kullman; S Hallhagen; T Ledin; I Ihse
Journal:  World J Surg       Date:  1988-12       Impact factor: 3.352

6.  Rapid induction of enterochromaffinlike cell tumors by histamine2-receptor blockade.

Authors:  O Nilsson; B Wängberg; L Johansson; E Theodorsson; A Dahlström; I M Modlin; H Ahlman
Journal:  Am J Pathol       Date:  1993-04       Impact factor: 4.307

7.  Amphicrine tumor.

Authors:  L Mándoky
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

Review 8.  The production and role of gastrin-17 and gastrin-17-gly in gastrointestinal cancers.

Authors:  Jeffrey Copps; Richard F Murphy; Sándor Lovas
Journal:  Protein Pept Lett       Date:  2009       Impact factor: 1.890

9.  Regression of type II gastric carcinoids in multiple endocrine neoplasia type 1 patients with Zollinger-Ellison syndrome after surgical excision of all gastrinomas.

Authors:  Melanie L Richards; Paul Gauger; Norman W Thompson; Thomas J Giordano
Journal:  World J Surg       Date:  2004-06-16       Impact factor: 3.352

10.  Gastroscopic follow up of pernicious anaemia patients.

Authors:  S M Sjöblom; P Sipponen; H Järvinen
Journal:  Gut       Date:  1993-01       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.